Skip to main
OPCH
OPCH logo

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 55%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc reported a robust growth in gross profit, reaching $269.0 million, which reflects an 8% year-over-year increase and surpasses prior estimates. The chronic therapy segment exhibited notable strength, achieving growth of over 10%, contributing to a positive trajectory in the company's financial performance. Furthermore, the company raised its revenue guidance for 2025 to a range of $5.5 billion to $5.65 billion, indicating an expected 12% year-over-year growth at the midpoint, which reinforces a favorable outlook for future operational results.

Bears say

The negative outlook on Option Care Health Inc. stems from several key financial concerns. Firstly, the company faces significant revenue and profitability risks due to its reliance on a single largest customer, which contributed 14% of its 2023 revenue, indicating that losing this customer could adversely impact overall earnings. Additionally, gross margin expansion appears limited due to the higher growth rates of lower-margin chronic therapies compared to higher-margin acute therapies, coupled with a projected gross profit headwind of over $20 million related to the Stelara item, which could hinder future operating leverage and EBITDA margin growth.

OPCH has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 55% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 11 analysts, OPCH has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.